BIOMAT Database Logo BIOMAT Database Logo

Incidence and clinical relevance of persistent iatrogenic atrial septal defect after percutaneous mitral valve repair. 2021

Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Department of Cardiology, Angiology and Intensive Care, Medical Clinic I, University Hospital RWTH Aachen, Pauwelsstrasse 30, 52074, Aachen, Germany.

Percutaneous mitral valve repair (PMVR) requires transseptal puncture and results in iatrogenic atrial septal defect (iASD). The impact of persistent iASD was previously investigated. However, data were diverse and inconclusive. 53 patients who underwent MITRACLIP were retrospectively included. Based on the presence of iASD in transesophageal echocardiography (TEE) after 6 months, patients were divided in two groups (iASD group vs. non-iASD group). Impact of iASD on outcome at 6 months and at two years was evaluated. Persistent iASD was detected in 62% of patients. Independent predictors for persistent iASD were female gender and reduced left ventricular ejection fraction. At 6-month follow-up, there was no difference in reduction of NYHA class (ΔNYHA = 1.3 ± 1 in iASD group vs. 0.9 ± 1 in non-iASD group, p = 0.171). There was a significant difference in right ventricular end diastolic diameter (RVEDd) (42 ± 8 mm in iASD-group vs. 39 ± 4 mm in non-iASD group, p = 0.047). However, right ventricular systolic function (TAPSE) (14 ± 7 mm in iASD group vs. 16 ± 8 mm in non-iASD group, p = 0.176) and right ventricular systolic pressure (RVSP) (40 ± 12 mmHg in iASD group vs. 35 ± 10 mmHg in non-iASD group, p = 0.136) were still comparable between both groups. At 2 years follow-up, there was no significant difference regarding rate of rehospitalization (24% vs 15%, p = 0.425) or mortality (12% vs 10%, p = 0.941) between both groups. Incidence of persistent iASD after MITRACLIP is markedly high. Despite the increase in right ventricular diameter in patients with persistent iASD, these patients were not clinically compromised compared to patients without persistent iASD.

UI MeSH Term Description Entries
D007049 Iatrogenic Disease Any adverse condition in a patient occurring as the result of treatment by a physician, surgeon, or other health professional, especially infections acquired by a patient during the course of treatment. Hospital-Acquired Condition,Condition, Hospital-Acquired,Conditions, Hospital-Acquired,Disease, Iatrogenic,Diseases, Iatrogenic,Hospital Acquired Condition,Hospital-Acquired Conditions,Iatrogenic Diseases
D008297 Male Males
D008943 Mitral Valve The valve between the left atrium and left ventricle of the heart. Bicuspid Valve,Bicuspid Valves,Mitral Valves,Valve, Bicuspid,Valve, Mitral,Valves, Bicuspid,Valves, Mitral
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D006344 Heart Septal Defects, Atrial Developmental abnormalities in any portion of the ATRIAL SEPTUM resulting in abnormal communications between the two upper chambers of the heart. Classification of atrial septal defects is based on location of the communication and types of incomplete fusion of atrial septa with the ENDOCARDIAL CUSHIONS in the fetal heart. They include ostium primum, ostium secundum, sinus venosus, and coronary sinus defects. Atrial Septal Defects,Ostium Primum Atrial Septal Defect,Persistent Ostium Primum,Atrial Septal Defect,Atrial Septal Defect Ostium Primum,Ostium Secundum Atrial Septal Defect,Defect, Atrial Septal,Ostium Primum, Persistent,Primum, Persistent Ostium,Septal Defect, Atrial
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic atrial septal defect persistence after percutaneous mitral valve repair: a meta-analysis.
April 2022, Acta cardiologica,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic Atrial Septal Defect After Percutaneous Mitral Valve Repair With the MitraClip System.
February 2018, The American journal of cardiology,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic atrial septal defect after mitral valve replacement.
January 1976, Acta clinica Belgica,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
When to close iatrogenic atrial septal defect after percutaneous edge to edge repair of mitral valve regurgitation.
September 2016, Cardiovascular revascularization medicine : including molecular interventions,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic Atrial Septal Defect After Percutaneous Mitral Valve Repair With MitraClip: Should We Consider Closing Them Routinely?
November 2020, The Journal of invasive cardiology,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Persistent iatrogenic atrial septal defect after pulmonary vein isolation : incidence and clinical implications.
September 2008, Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Risk of Percutaneous Iatrogenic Atrial Septal Defect Closure Required Shortly After Transseptal Mitral Valve Intervention.
December 2020, JACC. Cardiovascular interventions,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic Atrial Septal Defect Requiring Transcatheter Closure Following Transcatheter Mitral Valve Repair.
October 2022, Circulation journal : official journal of the Japanese Circulation Society,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Closure of Iatrogenic Atrial Septal Defect After Transcatheter Mitral Valve Repair: The Randomized MITHRAS Trial.
January 2021, Circulation,
Mhd Nawar Alachkar, and Anas Alnaimi, and Sebastain Reith, and Ertunc Altiok, and Jörg Schröder, and Nikolaus Marx, and Mohammad Almalla
Iatrogenic atrial septal defect post mitral valve in valve implantation.
December 2018, Cardiovascular revascularization medicine : including molecular interventions,
Copied contents to your clipboard!